ArticleJournal of chemical information and modeling2026
Assessing Molecular Dynamics in Predicting Aptamer-Ligand Binding Thermodynamics: Insights from the OTA Binding Aptamers.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The targeting of nucleic acid platforms is of particular interest in biochemistry and pharmaceutical applications. Among nucleic-based structures, aptamers, short, synthetic oligonucleotides, stand out because of their tunable sequences, enabling highly selective recognition of molecules of different sizes. However, an accurate evaluation of aptamers' affinity toward their targets remains elusive, as results obtained from different experimental techniques are often inconsistent. In this context, computational methods provide an appealing alternative for characterizing aptamer binding and structure. To this end, we selected two ochratoxin A binding aptamers as a case study to assess the ability of molecular dynamics simulations and alchemical free energy calculations to model the conformational dynamics and binding thermodynamics of these systems. Extensive classical molecular dynamics simulations were performed to characterize the aptamers' structures in the absence of their ligand, which could not be determined experimentally due to the intrinsic flexibility of these sequences. Additional simulations on aptamer-ligand complexes provided atomistic details of the interactions underlying the corresponding aptamers' preferential binding to their target compared with an analogue ligand that differs by a single atom. Lastly, alchemical free energy calculations were employed to estimate aptamers' selectivity for the target over its analogue, expressed as relative binding free energy. Our estimates are in good agreement with experimental data. We expect these computational strategies to contribute to future protocols for aptamer design and evaluation, enabling a more rigorous assessment of their binding to biochemically relevant molecules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.